http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109833440-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_524b4a8f23ac2851fcc8296c3151e870 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
filingDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50e35789c8f98b7dbacea3e47f7c5ac |
publicationDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109833440-A |
titleOfInvention | A formula for treating hepatitis C |
abstract | The invention relates to a formula for treating hepatitis C. The raw materials in the formula are respectively composed of 5-15% by weight of bacteria, 1-5% of Bupleurum, 1-10% of Astragalus, 5-15% of Salvia miltiorrhiza, gentian ca. 3‑9%, Banlangen 2‑3%, Poria 1‑5%, Polyporus 11‑19%, Dandelion 5‑7%, Lycium barbarum 3‑5%, Weed 3‑5%, Money grass 1‑5 %, American ginseng 5-10%, Schisandra 1-1.5%, Ligustrum lucidum 4-5%, Shandou root 2-4%, Tuckahoe 0.4-0.6%, Shengyiren 1-2%, Gentiana 2-4 %, borneol 1-3%, the treatment of hepatitis C of the present invention has the effect of stabilizing blood pressure without rebounding, long-term stable blood pressure, no need for long-term medication, no drug resistance, safety and no side effects, suitable for a wide range of people, and is a caring medicine for the common people. . |
priorityDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.